In a significant fraction of breast cancer patients, distant metastases emerge after years or even decades of latency. How disseminated tumour cells (DTCs) are kept dormant, and what wakes them up, are fundamental problems in tumour biology. To address these questions, we used metastasis assays in mice and showed that dormant DTCs reside on microvasculature of lung, bone marrow and brain. We then engineered organotypic microvascular niches to determine whether endothelial cells directly influence breast cancer cell (BCC) growth. These models demonstrated that endothelial-derived thrombospondin-1 induces sustained BCC quiescence. This suppressive cue was lost in sprouting neovasculature; time-lapse analysis showed that sprouting vessels not only permit, but accelerate BCC outgrowth. We confirmed this surprising result in dormancy models and in zebrafish, and identified active TGF-β1 and periostin as tumour-promoting factors derived from endothelial tip cells. Our work reveals that stable microvasculature constitutes a dormant niche, whereas sprouting neovasculature sparks micrometastatic outgrowth.
It has been difficult, if not impossible, to predict whether and when metastases will occur 1 . The reason is that although the metastatic cascade is depicted typically as a linear process, in reality it is anything but. Some patients may experience metastatic relapse within months whereas others go several years or even decades without distant recurrence 1-4 . The recent discovery of tumour-promoting milieus (referred to as metastatic niches [5] [6] [7] ) established at distant sites before, or on, the arrival of DTCs could explain the population that relapses early. However, in late-relapsing populations, what tumour cells do from the time of dissemination to the time they become clinically detectable is an outstanding question. Studies in mice and analysis of human clinical specimens revealed that single or small clusters of DTCs may persist long-term in a state of quiescence 2, [8] [9] [10] . Precisely where these cells reside, how they are induced into a dormant state and what eventually causes them to awaken remain perplexing mysteries in tumour biology. Solving these problems is key to designing therapies that prevent relapse by either sustaining tumour dormancy or by selectively killing off dormant cells with minimal damage to normal tissues 11 .
We have long argued and provided evidence that basement membrane, in particular laminin-111, provides a hospitable microenvironment that allows mammary epithelial cell survival, quiescence and resistance to cytotoxic agents [12] [13] [14] [15] [16] [17] , three properties commonly associated also with dormant DTCs (ref. 18 ). Thus, we suspected that basement membrane was a major component of the dormant niche in distant organs. Given that BCCs must take a haematogenous route to arrive at sites where breast tumours metastasize most often (that is, lung, bone marrow (BoMa), brain and liver) 19 , the microvascular basement membrane would be the first of its kind encountered by tumour cells as they disseminate to these tissues. Therefore, we reasoned that endothelial cells (ECs)-and factors deposited within their surrounding basement membrane-may be a prime player within the dormant niche.
To test this hypothesis, we used two mouse models of human breast cancer metastasis and discovered that dormant DTCs reside on the microvasculature of lung, BoMa and brain. By creating organotypic models of lung-and BoMa-microvascular niches, we demonstrated that ECs induce and sustain BCC quiescence. cells were injected into the inguinal mammary gland of NOD-SCID mice. Tumours were resected at 3 weeks (V avg = 0.5 cm 3 ; representative bioluminescence shown). Mice that were relapse-free after 6 weeks (4/20 mice) were euthanized and visceral organs were dissected. (b) Representative image of a primary tumour section fixed and stained for endothelial-specific marker CD31 (red), and cell cycle marker Ki67 (white). DNA was labelled with Hoechst 33342 (blue).
(c,d) Dormant (Ki67-negative) DTCs (white asterisks) were found residing on microvascular endothelium in lung (c) and BoMa (d) tissues isolated from mice euthanized 6 weeks after primary tumour resection. (e) mCherry T4-2 cells (false-coloured green here for consistency) were introduced through intra-cardiac injection, and mice that did not show any evidence of metastatic burden were euthanized 8 weeks later. (f-h) In this second model, dormant (Ki-67-negative) T4-2 BCCs (white asterisks) also were found residing perivascularly in lung (f), bone marrow (g) and brain (h). Scale bars, 20 µm.
Proteomic and functional analyses of proteins deposited in organotypic microvascular niches identified thrombospondin-1 (TSP-1) as an endothelium-derived tumour suppressor. Importantly, TSP-1 was diminished near sprouting neovasculature, suggesting that tumours may escape growth regulation in this sub-niche. Time-lapse analysis confirmed that tumour growth was not just permitted, but in fact accelerated around neovascular tips, which we show are rich in tumour-promoting factors such as active TGF-β1 and periostin (POSTN). These findings establish a paradigm of differential regulation of DTC dormancy and relapse by distinct endothelial sub-niches, and suggest that preserving vascular homeostasis is critical to maintaining dormancy of DTCs.
RESULTS

Dormant DTCs reside on microvascular endothelium
To determine whether dormant DTCs occupy a specific niche, we searched first for DTCs lacking expression of the cell cycle marker Ki67 in a spontaneous metastasis model of breast cancer 20 . Tumours resulting from orthotopic injection of MDA-MB-231, a bona fide metastatic BCC line expressing GFP-luciferase, were resected after 3 weeks (V avg = 0.5 cm 3 , Fig. 1a ). Surviving mice that did not experience relapse at the primary site were euthanized 6 weeks later. Bioluminescence of dissected visceral organs confirmed that BCCs disseminated to the canonical target organs-lung, bone, liver and brain 21 (Fig. 1a) . In contrast to the resected primary tumours, in which BCCs proliferated * * * actively whether nearby tumour vasculature or not ( Fig. 1b ), we found small clusters of GFP-positive/Ki67-negative BCCs residing directly on microvascular endothelium of both lung ( Fig. 1c ) and BoMa (Fig. 1d ).
This observation was confirmed also with a weakly metastatic BCC line (mCherry HMT-3522-T4-2; ref. 22) , which was injected intra-cardially to facilitate dissemination to all target organs ( Fig. 1e ).
Eight weeks after injection into the left ventricle of NOD-SCID mice, small clusters of mCherry-positive (false-coloured green)/Ki-67negative T4-2 cells were found residing perivascularly in murine lung ( Fig. 1f ), BoMa ( Fig. 1g ) and brain (Fig. 1h ). The consistent discovery of quiescent DTCs residing perivascularly-6 weeks after resection of the primary tumour in the first model, and 8 weeks post-injection in the second model-suggested that endothelium might play an active role in regulating tumour dormancy.
Organotypic microvascular niches demonstrate that endothelial cells induce sustained quiescence of BCCs
Determining whether microvascular endothelium could directly influence tumour cell quiescence necessitated lung-and BoMa-like designer microenvironments that would allow quantitative assessment of human BCC growth in the presence or absence of a microvascular network. There are considerable hurdles to engineering such models. For example, whereas ECs do not survive in serum-and cytokine-free medium (SFM), the addition of exogenous factors could mask the effects of EC-derived angiocrine factors on tumour growth [23] [24] [25] .
To overcome this limitation, primary human umbilical vein endothelial cells (HUVECs) were transduced with a lentiviral construct containing the human adenoviral E4ORF1 gene 24 , which enables HUVECs to survive 24 and form sustainable microvascular networks in SFM ( Supplementary Fig. S1 ). E4ORF1-HUVECs (E4-ECs) expressing mCherry self-assembled into robust three-dimensional (3D) microvascular networks 26 over 7 days when cultured with fibroblasts from lung (LFs) or with BoMa mesenchymal stem cells (MSCs). We then compared the growth of yellow fluorescent protein (YFP)-expressing T4-2 cells seeded sparsely in SFM onto lung-and BoMa-like microvascular niches or onto only the corresponding stroma (that is, LFs or MSCs) after a further 10 days ( Fig. 2a ). Whereas T4-2 cells grew extensively on lung and BoMa stroma, growth of T4-2 cells on organotypic microvascular niches was reduced markedly (threefold in lung-like-and fivefold in BoMa-like-microenvironments; Fig. 2b-d ). Similar results were obtained also with a luminal, oestrogenreceptor-positive BCC line (MCF-7; Supplementary Fig. S2a,b ). Highly metastatic MDA-MB-231 cells exhibited the same trend; in particular, cells adherent to microvasculature were Ki67-negative ( Supplementary  Fig. S2c -e). Ki67 immunofluorescence ( Fig. 2b , inset) revealed further that most T4-2 cells seeded in organotypic microvascular niches became quiescent (77.4% Ki67-negative clusters in lung-like niche and 88.1% in BoMa-like niche; Fig. 2e ,f). Importantly, this was not a transient phenotype, as microvasculature-associated tumour clusters generally remained dormant, as opposed to BCCs cultured only on lung or BoMa stroma ( Fig. 2g-j) . Thus, our organotypic models recapitulated our in vivo findings and allowed us to pinpoint ECs as a prime regulator of DTC quiescence in lung and BoMa. We next sought to identify endothelium-derived factor(s) underlying this effect.
TSP-1 is deposited around mature endothelium and is an angiocrine tumour suppressor
We noted consistently that whereas the bulk of quiescent tumour clusters remained on or near microvascular endothelium in our culture models, those that had seeded-or strayed-to the edge of a well and off of microvasculature typically underwent marked expansion ( Supplementary Fig. 3a ; inset shows that all clusters originated from single cells). This observation hinted that the putative angiocrine tumour suppressor(s) was not freely diffusible. Indeed, medium conditioned daily by microvascular niche cultures did not reduce T4-2 cell growth on lung stroma when compared to control conditions ( Supplementary Fig. S3b,c) .
Accordingly, to identify factors deposited locally by ECs that could suppress tumour cell growth, we performed comparative proteomics on decellularized extracellular matrix (ECM) from lung-and BoMa-like microvascular niches (versus their respective stroma). A number of extracellular factors were upregulated in organotypic microvascular niches ( Fig. 3a ). Among these potential angiocrine tumour suppressors, TSP-1 caught our attention because: TSP-1 was expressed at higher levels in both organotypic lung-and BoMa-microvascular niches when compared with stroma alone (Fig. 3a) , and TSP-1 overexpression in BCCs was shown previously to suppress metastatic outgrowth in lung 27 . However, these anti-tumour effects were attributed to the anti-angiogenic activity of TSP-1 (ref. 27) . The possibility that TSP-1 could function to directly suppress tumour cell growth (particularly from a non-tumour source within the DTC microenvironment) had not been considered 28 .
We verified first that TSP-1 was present on lung microvessels associated with dormant DTCs in both spontaneous and experimental metastasis models (Fig. 3b,c ). We confirmed also that TSP-1 is expressed in non-tumour-bearing mice in the microvascular basement membrane of murine lung ( Fig. 3d ), bone ( Fig. 3e ) and brain ( Fig. 3f ). Similar peri-endothelial localization was observed also in organotypic microvascular niches. To determine whether perivascular TSP-1 is derived primarily from ECs, we used a 3D co-culture model consisting of EC-coated microcarrier beads embedded within a fibrin ECM several millimetres away from overlaid LFs. ECs form robust microvascular networks after 7 days under these conditions 29 , and TSP-1 was concentrated within the basement membrane of established microvessels ( Fig. 3g,h ). Gain-of-function studies confirmed that TSP-1 was sufficient to suppress BCC growth on lung stroma in the absence of endothelium ( Fig. 3i ). Furthermore, pre-treatment with a TSP-1-blocking antibody to interfere with T4-2 cell adhesion to TSP-1 within lung-like microvascular niches resulted in significantly increased tumour cell outgrowth when compared with IgG control-treated cultures (Fig. 3j ). These gain-and loss-of-function experiments, combined with its presence in microvascular basement membrane and its association with dormant DTCs, identified TSP-1 as an angiocrine tumour suppressor.
Neovascular tips accelerate breast tumour cell outgrowth
As TSP-1 stabilizes microvascular endothelium by inhibiting EC motility and growth 28 , it was not surprising to find it expressed surrounding established microvasculature ( Fig. 3d-g ). However, loss of TSP-1 expression at neovascular tips ( Fig. 3g ,h) suggested that this physiological knockdown could result in a concomitant loss of tumour suppression within neovascular sub-niches. In support of this idea, we found that quiescent tumour clusters were often associated with stable endothelial stalks ( Fig. 4a (i); asterisk, and also a(ii)-(iv), all from the same culture), whereas actively growing tumour clusters were often surrounded by sprouting neovascular tips ( Fig. 4a (i); T). Therefore, we reasoned that these two sub-niches exert differential growth control over BCCs. TSP-1 co-localized with type IV collagen in the basement membrane of established microvessel stalks (white arrowheads), but TSP-1 seemed to be downregulated at neovascular tips (white asterisks). Scale bar, 50 µm. t dwell /t div 0d00:00:00.000 0d18:00:00.000 1d12:00:00.000 2d06:00:00.000 2d23:40:00.000 2d23:40:00.000 2d06:00:00.000 1d12:00:00.000 Neovascular tip: Movies S1 and S2). White arrowheads denote approaching tip and subsequent T4-2 division. Scale bars, 100 µm (left-most panel) and 50 µm (right panels). (c) Scatter plot of T4-2 cell dwell time fraction (t dwell /t div ) within stable (t dwell,stable ), neovascular (t dwell,neo ) or stromal (t dwell,stroma ) sub-niches versus division time (t div , n = 229 cells pooled from 3 separate time-lapse experiments). Pearson correlation analysis yielded significant correlation of t dwell,stable with t div and significant anti-correlation of t dwell,neo with t div , meaning that BCCs with longer division times tended to dwell more around stable endothelium and less around neovascular tips. Pearson coefficients (r ) for stable endothelium, neovascular tips and stroma are listed to right of the plot. * P = 0.014 and * * P = 0.001 (two-tailed). Malignant T4-2 cells expressing histone H2B-GFP were seeded on top of microvascular niches and tracked for 72 h. Qualitative analysis of time-lapse videos revealed that tumour cells remaining near established vessel stalks divided more slowly than those that encountered neovascular tips ( Fig. 4b ; Supplementary Videos S1 and S2). To perform quantitative analysis, we defined 3 sub-niches: neovascular tip, for tumour cells within 50 µm of a sprouting endothelial tip; stable endothelium, for tumour cells within 50 µm of established, non-invasive endothelium; and stroma, for tumour cells >50 µm away from either type of endothelium. We quantified the aggregate time (that is, dwell time, t dwell ) that 229 tumour cells spent in each of these sub-niches before undergoing a single division (division time: t div ). Thus, in Fig. 4c , the scatter plot represents the fraction of each T4-2 cell's t div spent near stable (red) or neovascular (green) endothelium, or on stroma (black). Pearson correlation analysis revealed that dwell time around stable endothelium (t dwell,stable ) correlated significantly * with t div (two-tailed Pvalue = 0.014); that is, BCCs with longer division times tended to reside longer near established endothelium ( Fig. 4c , red trend line). Conversely, tumour cell dwell time around neovascular tips (t dwell,neo ) anti-correlated significantly with t div (twotailed P value = 0.001; green trend line in Fig. 4c ). Importantly, stromal dwell time (t dwell,stroma ) did not correlate with t div (Fig. 4c , black trend line) at all. We extended this analysis further by examining the fastest-(t div < t avg − s.d.) and slowest-(t div > t avg + s.d.) dividing tumour cells and found that the fastest-dividing tumour cells resided 2.1 times longer within neovascular sub-niches than around stable endothelium, whereas the slowest-dividing tumour cells did the opposite (Fig. 4d ). Our analysis suggested that established endothelium steers BCCs towards a quiescent phenotype, whereas neovascular endothelium accelerates BCC growth. If this were indeed true, tumour growth should decrease if neovascular tips are depleted before tumour cell seeding, and increase if neovascular tip formation is promoted. Consistent with observations from the developing mouse retina 30 , reduced expression of endothelial Notch1 through Notch1 targeting short hairpin RNA (shRNA; Supplementary Fig. S4 ) led to a hyperbranched network, but with a significant reduction in the number of endothelial tips ( Fig. 5a-c) . This was to be expected from a closed system (our case), as opposed to an open system (the developing retina 30 ). BCC growth followed suit, evidenced by the progressive reduction in growth of T4-2 cells seeded on either control shRNA (tip high )-, control shRNA:Notch1 shRNA chimaera (1:1)-or Notch1 shRNA (tip low )-EC cultures (Fig. 5d,e ). The percentage of quiescent tumour clusters also increased modestly in cultures that contained fewer neovascular tips (Fig. 5f ).
We investigated also whether increased neovascular tip concentration would promote tumour cell growth in culture and in vivo. To enrich for neovascular tips in culture, we allowed microvascular networks to develop for only 3 days before seeding T4-2 cells. The number of neovascular tips at day 3 of network formation was nearly double that of day 7 cultures ( Supplementary Fig. S5a,b,e ). Seeding tumour cells at each of these developmental time points and measuring growth 10 days later confirmed that BCC growth correlates positively with endothelial tip number; T4-2 cells grew nearly 6 times more when seeded on networks rich in neovascular tips, and significantly fewer of these tumour clusters became quiescent ( Supplementary Fig. S5c,d,f,g) .
To investigate whether a microenvironment rich in neovascular tips promotes tumour cell growth in vivo, we used zebrafish with a mutation in the gene encoding microsomal triglyceride transfer protein (mtp). These mutants, called stalactite, have an ectopic microvascular sprouting phenotype that is especially pronounced in the perivitelline/subintestinal space at 3.5 days post-fertilization (dpf; ref. 31 ). Accordingly, we injected ∼1-10 MDA-MB-231 cells expressing mCherry into the subintestinal space of wild-type (WT) and mtp −/− mutant zebrafish at this time point. Fish injected unsuccessfully, defined as those lacking red fluorescence in the subintestinal space, or those over-injected (an area fraction of red fluorescence over a pre-determined threshold value), were discounted from further analysis. Successfully injected zebrafish were imaged four days later (7.5 dpf; mtp −/− mutants perish shortly thereafter 31 - Fig. 6a ). On average, mtp −/− mutants had 4 times more neovascular sprouts than their WT siblings at the time of injection ( Fig. 6b-d) . In WT fish that survived until 7.5 dpf and had viable MDA-MB-231 cells in their subintestinal space, those that adhered to subintestinal vessels did not grow appreciably ( Fig. 6e ,g; note that for each fish, tumour cell area fraction at 7.5 dpf was normalized to the corresponding value obtained just after injection to account for variations in initial seeding density). In contrast, tumour cells injected into the subintestinal space of mtp −/− mutants expanded significantly more than those in WT siblings, particularly in the vicinity of neovascular tips (Fig. 6f,g) .
Neovascular tips constitute micrometastatic niches rich in periostin and active TGF-β1
The above experiments confirmed that neovascular tips promote tumour cell outgrowth in organotypic culture and in vivo, implying production of distinct tumour-promoting factors by neovascular tip cells. To identify factors enriched around neovascular tips, we used tandem mass spectrometry and compared decellularized ECM from neovascular tip high (control shRNA) and tip low (Notch1 shRNA) cultures (Fig. 5a ). Tip high cultures were characterized by enhanced expression of POSTN, tenascin, versican and fibronectin (Fig. 7a ), all molecules involved in formation of the metastatic niche 5,32-35 . Further, tip high cultures exhibited reduced expression of molecules involved in sequestering another known mediator of metastatic outgrowth, TGF-β1 (biglycan and LTBP1, Fig. 7a ) 36 , suggesting that active TGF-β1 itself would be expressed more highly at neovascular tips. Immunofluorescent staining of E4-ECs in 3D co-cultures confirmed that active TGF-β1 and POSTN were expressed highly at neovascular tips (Fig. 7b,c,e ). In contrast, latent TGF-β1 was expressed prominently in endothelial stalks (Fig. 7d) . These findings were confirmed in vivo in physiologic and pathologic settings. POSTN and active TGF-β1 were concentrated on/near endothelial tip cells in the developing mouse retina ( Supplementary Fig. S6a,c,e ), but were not detected consistently around established phalanx endothelium in the same tissue ( Supplementary Fig. S6c,e; Protein S100-A11 S100A11 Protein S100-A16 S100A16 Protein S100-A13 S100A13 Matrix-remodelling-associated protein 5 MXRA5 Sushi repeat-containing protein SRPX SRPX Angiomotin-like protein 1 AMOTL1 Protein S100-A6 S100A6 Protein S100-A9 S100A9 Collagen α-1(III) chain COL3A1 EGF, atrophilin and seven transmembrane domain-containing protein 1 ELTD1 Lysyl oxidase homologue 2 LOXL2 TGF-β-related proteins: Growth/differentiation factor 15 GDF15 Latent-transforming growth factor β-binding protein 4 LTBP4 Transforming growth factor-β-induced protein ig-h3 TGFBI Latent-transforming growth factor β-binding protein 2 LTBP2 CD109 antigen CD109 Latent-transforming growth factor β-binding protein 1 LTBP1 Biglycan BGN * * * P < 0.0001 by two-tailed t -test. (i) A visual summary of our findings is as follows. In distant microenvironments, single or small clusters of DTCs reside in the perivascular niche and are maintained in a quiescent state by endothelial-derived factors. Here, we have identified TSP-1 as one such factor, and perlecan was identified by others as an EC-derived factor that suppresses tumour growth 47 . Other ECM molecules such as laminins, type IV collagen and latent TGF-β-binding proteins (LTBPs) may contribute directly or indirectly to the dormant niche. As vascular homeostasis is disrupted with induction of neovascular sprouting, endothelial architecture is perturbed. The result is not only loss of suppressive signals (for example, TSP-1), but deposition of ECM molecules and growth factors that promote micrometastatic outgrowth. Thus, maintaining vascular homeostasis could be the key to sustaining DTC dormancy long-term.
insets). Examining established
metastases revealed that in this setting, POSTN and active TGF-β1 were deposited prominently around endothelial tip cells as well ( Supplementary Fig. S6b,d,f) . In contrast, expression of both factors near non-tumour-associated endothelium within the same tissue sections was diminished ( Supplementary Fig. S6d,f; insets) . Pulsing POSTN and TGF-β1 into microvascular niche cultures to recapitulate a tip-enriched microenvironment promoted BCC growth; T4-2 cells seeded on lung-like microvascular niches and treated transiently with POSTN and TGF-β1 (twice over the first 48 h to mimic the brief interaction of tumour cells with neovascular tips) experienced 3 times more outgrowth when compared with vehicle-treated counterparts ( Fig. 7f-h) . This finding confirms that POSTN and TGF-β1, which are expressed highly at neovascular tips, promote BCC outgrowth within a tumour-suppressive microenvironment.
DISCUSSION
Using murine models, zebrafish and organotypic microvascular niches composed of human cells, we demonstrate here that: dormant DTCs from the breast reside on or near lung and BoMa microvasculature in vivo, stable microvasculature constitutes a dormant niche that induces sustained tumour cell quiescence through TSP-1, and the tumour-suppressive nature of microvascular endothelium is lost at sprouting endothelial tips, which are characterized by reduced TSP-1 expression and enhanced expression of pro-tumour factors POSTN and TGF-β1 (Fig. 7i ). Studies of primary tumours have focused primarily on the tumour's regulation of the endothelium. We believe this paradigm now shifts at secondary sites, where DTCs are the minority constituent of the tissue and subject to direct control by microvascular endothelium and perhaps other resident cell types. The notion that ECs directly regulate cells in the perivascular microenvironment is rooted in a number of biological studies on normal tissues (reviewed in ref. 25) . ECs with phenotypic characteristics of neovascular tip cells spark growth and morphogenesis of the liver 37 and regeneration of lung alveoli 38 . On the other hand, established endothelium promotes pancreatic differentiation 39 , inhibits smooth muscle cell proliferation 40 and maintains pluripotency of neural, haematopoietic and mesenchymal stem cells 23, [41] [42] [43] [44] . Our study demonstrates that this scenario-that mature microvasculature confers tissue quiescence and sprouting endothelium promotes tissue growth-is at work also in the DTC microenvironment. These findings may apply generally to primary tumours also, thus shedding light on the apparent dichotomy of EC function at the primary site [45] [46] [47] [48] [49] .
The therapeutic implications of our results are multi-fold. Foremost is that identification of tumour-suppressive factors derived from stable endothelium may guide therapies designed to enforce DTC dormancy. This raises the question of whether other molecules in the microvascular basement membrane function as tumour suppressors, and whether these can be used in combination with TSP-1 to stave off metastatic relapse. Second is that factors enriched in neovascular sub-niches may be targeted early in tumour progression to prevent establishment of micro-metastatic niches that disrupt DTC quiescence. In this regard, our study complements previous work pinpointing POSTN, TGF-β1 and other molecules as potential therapeutic targets 5, [32] [33] [34] [35] [36] , and reveals further that these molecules arise from an unexpected source, namely neovascular endothelium.
Surprisingly, many of the factors upregulated in neovascular tip-enriched cultures are documented components of pre-metastatic and metastatic niches 5, 7, [32] [33] [34] . Given the nature of our results, this commonality provides further evidence for the in vivo relevance of our model systems. It also raises a question about whether metastatic niche formation is dependent on the induction of neovasculature. In this respect, it is interesting to note that nascent endothelium was shown recently to initiate a Th2-mediated inflammatory response in asthma 50 , a response that is also associated with accelerated metastatic outgrowth in tumour models [51] [52] [53] . Thus, by direct deposition of tumour-promoting factors, as well as by secreting cytokines that stimulate macrophage polarization to a pro-tumour phenotype 50, 53 , neovascular tips may function as a nexus that directly and indirectly catalyses formation of a micrometastatic niche. Accordingly, long-term administration of drugs aimed at preventing neovascular formation 54 through inhibition of VEGFR2-(ref. 55) or integrin α v β 3 -(ref. 56) driven signalling, or by targeting more recently discovered proangiogenic signalling mechanisms 57 , may prove effective in delaying relapse of early-stage breast cancer patients. We believe that it will be crucial to deliver these drugs in a manner that prevents cultivation of the pro-tumour neovascular niche while preserving the dormant niche fostered by stable microvasculature.
It remains to be determined whether the mechanisms we have identified here apply also to other tumour types and in other secondary tissues. We propose that a systematic understanding of interactions between DTCs and their microenvironment will provide a vehicle by which we can design more effective therapies to keep DTCs dormant-or eradicate them-in early-stage cancer patients.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb2767 METHODS Animal studies. All mouse work was performed in accordance with institutional, IACUC and AAALAS guidelines. For spontaneous metastasis assays, GFP-luc MDA-MB-231 (1 × 10 6 cells) were injected into the inguinal mammary gland of 7-week-old female NOD-SCID mice (20 total; Charles River) in a 1:1 solution of LrECM (Growth-factor reduced Cultrex; Trevigen): Dulbecco's modified Eagle's medium (DMEM; Invitrogen/Gibco). Tumours 0.5 cm 3 were resected 3 weeks later. Mice were monitored weekly for relapse by bioluminescence imaging and those that did not experience gross metastatic relapse early on were euthanized and dissected at 6 weeks. Lungs were collected after saline perfusion. Primary tumours and lungs were fixed overnight in 1.6% paraformaldehyde (PFA)/PBS solution and then banked in optimum cutting temperature (OCT) compound (Tissue-Tek). Femurs and tibia were fixed in an identical fashion and then decalcified by gentle shaking in decalcification solution (0.1 M Tris-HCl, 0.26 M EDTA, at pH 7.4) for 1 week protected from light and with intermittent changes of decalcification solution before overnight incubation in 30% sucrose, incubation in 1:1 sucrose/OCT (1 h overnight), and finally embedding in OCT compound.
For experimental metastasis assays, mCherry T4-2 cells (1 × 10 5 cells in 100 µl PBS) were injected into the left cardiac ventricle of 6-8-week-old female NOD-SCID mice with a 26 1/2 gauge needle. Successful injection was characterized by the pumping of arterial blood into the syringe. Mice that did show any signs of tumour burden were euthanized and dissected 8 weeks post-injection. Tissues were processed as described above.
For the retinal angiogenesis assay, retinas were dissected from P5 C57BL/6 mice, whole-mounted and stained as described elsewhere 59 . Antibodies used for staining are detailed below.
Establishment and characterization of Tg(fli1:eGFP) y1 and mtp −/− (also known as stalactite) mutant zebrafish lines have been described previously 31 and were generously provided by B. Weinstein (NICHD/NIH, USA). Embryos and adult zebrafish were maintained under standard laboratory conditions, as described previously 60 . Injection of mCherry MDA-MB-231 cells into the perivitelline/subintestinal space of 3.5 dpf mtp −/− mutants and WT siblings was conducted essentially as described previously 61 , except the cellular solution was diluted such that ∼1-10 MDA-MB-231 cells were injected per fish. Fish were incubated for four days post-injection and fixed at 7.5 dpf. Quantification was performed as detailed below.
Immunofluorescent staining. Serial tissue sections (thickness: 50 µm) of primary tumours, lungs, bones and brains were generated with a Leica CM3050 S cryostat (Leica Microsystems). Sections were thawed, rehydrated in PBS and incubated in 0.1 M glycine/PBS overnight to neutralize PFA activity. Tissues were then rinsed extensively with PBS and stained as described elsewhere 62 . In tissue sections and in whole-mounted retina, endothelial cells were labelled with a rat monoclonal antibody targeting CD31/PECAM-1 (BD Pharmingen 553373, clone: MEC 13.3, 1:250), TSP-1 was stained with a rabbit polyclonal antibody (Abcam ab85762, 5 µg ml −1 ), POSTN was stained with a mouse monoclonal antibody (AdipoGen AG-20B-0033, clone: Stiny-1; 5 µg ml −1 ), active TGF-β1 was stained with a chicken polyclonal antibody (R&D Systems AF-101-NA, 2 µg ml −1 ), and proliferating cells were identified with a rabbit polyclonal antibody targeting Ki67 (Vector Laboratories VP-K451, 1:500) or a mouse monoclonal antibody targeting PCNA (Abcam ab29, clone: PC10, 1 µg ml −1 ). Hoechst 33342 (Sigma) was used to label cellular nuclei. Secondary antibodies used were goat anti-rat 488 or 568 and goat anti-rabbit 405 or 633 (Invitrogen), all at 1:500. Tissues were imaged on a Zeiss LSM 710 confocal microscope using either a 1.1 NA ×40 water-immersion objective or a 1.4 NA ×63 oil-immersion objective.
Three-dimensional cultures (see below) were stained after fixation with Alexa Fluor 568 phalloidin (Invitrogen A12380, 1:200) to detect F-actin or with the following antibodies: mouse monoclonal antibody targeting human CD31/PECAM-1 (Millipore CBL468, clone: HC1/6 1:200), rabbit polyclonal antibody against Ki67 (see above), rabbit polyclonal antibody against periostin (Abcam ab14041, 1:100), chicken polyclonal antibody against active TGF-β1 (see above), goat polyclonal antibody against LAP TGF-β1 (R&D Systems AB-246-BA, 10 µg ml −1 ), and mouse monoclonal antibody against type IV collagen (University of Iowa Developmental Studies Hybridoma Bank, clone: M3F7, 1:100).
Cell culture and reagents. HUVECs isolated freshly from human umbilical cord veins were propagated in EGM-2 growth medium (Lonza). Human MSCs and LFs were obtained commercially (Lonza) and propagated in low-glucose (MSCs) or highglucose (LFs) DMEM supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals) and 1% penicillin/streptomycin (P/S; UCSF Cell Culture Facility). All primary human cells were used in experiments before passage 10.
Malignant T4-2 cells were grown in H14 medium on collagen-coated tissue culture flasks. MCF-7 and MDA-MB-231 cells were grown in high-glucose DMEM supplemented with 10% FBS and 1% P/S. mCherry E4-ECs were generated by retroviral infection of E4-ECs with a pBMN/mCherry plasmid 29 . YFP-T4-2, -MCF-7 and -MDA-MB-231 were generated by infection of tumour cells with pLentiCMV/YFP lentivirus followed by selection for 96 in 1 µg ml −1 puromycin. Histone H2B-GFP T4-2 have been described previously 63 .
Generation of E4ORF1 lentivirus and E4ORF1-HUVECs. pCCL-PGK lentivi-
ral vector containing the human adenoviral E4ORF1 gene (serotype 5) was a gift from S. Rafii (Weill Cornell Medical College, HHMI, USA; ref. 24) . Lentivirus was generated by co-transfection of sub-confluent 293FT cells with 2 µg each of PLP1, PLP2, VSVG and E4ORF1 plasmid DNA in DMEM containing a 3:1 (µl:µg) ratio of FuGene6 (Roche)/total plasmid DNA. 293FT medium was changed to growth medium 24 h after transfection and lentivirus was collected 48 h later. HUVECs were infected at a multiplicity of infection of 5 using the Mission ExpressMag Supermagnetic Kit (Sigma) as per the manufacturer's instructions, and then selected for 96 h in totally unsupplemented DMEM/F12 medium.
Microvascular niche cultures.
Microvascular niche cultures were generated with modifications to a previously described protocol 26 . LFs or MSCs were seeded alone at a density of 5×10 4 cells per well in 96-well culture plates or with mCherry E4-ECs at a 5:1 ratio to generate lung-like or BoMa-like microvascular niches, respectively. Cells were suspended in EGM-2 at a concentration of 5×10 4 cells per 100 µl (stroma alone) or 6 × 10 4 cells per 100 µl (stroma + ECs). After depositing 100 µl of cellular suspension per well of a 96-well plate, plates were left undisturbed on a flat surface for 20 min to allow even cell seeding before incubation.
After 7 days, YFP tumour cells were suspended in unsupplemented DMEM/F12 (800 cells ml −1 ). YFP tumour cells were seeded (100 µl well −1 ) after washing cultures three times with PBS. Cells were allowed to settle for 15 min at room temperature, and then a drip of LrECM (ref. 58) in DMEM/F12 was slowly added to each well (final concentration = 20%). The drips condensed for 10 min at room temperature before polymerizing fully at 37 • C before imaging. Cultures were imaged immediately after seeding on a Zeiss LSM 710 confocal microscope using a 0.3 NA ×10 air objective. The objective was centred to each well before acquisition of 6 × 6 tiles that captured the near-entirety of each well. Cultures were maintained with media changes every 72 h and imaged again at day 10.
For TSP-1-blocking antibody experiments, cultures were treated at day 5 and again at day 7 (on tumour cell seeding) with 20 µg ml −1 of a mouse monoclonal antibody that blocks binding of CD47 to TSP-1 (Thermoscientific MS-420-P1ABX, clone: C6.7), or with 20 µg ml −1 of IgG 1 control (Acris Antibodies AM03095AF-N).
Time-lapse acquisition. Time-lapse sequences were acquired with a Zeiss LSM 710 confocal microscope fitted with an environmental chamber to maintain temperature (37 • C), humidity and CO 2 (5%). H2B-GFP T4-2 cells were starved for 24 h in unsupplemented DMEM/F12 before seeding on microvascular niches (see above). Images (6 × 6 tiles, 512 × 512 resolution, 8-bit) were acquired every 20 min for 72 h. Medium was replenished at 24 h. Three-dimensional sprouting angiogenesis assay. E4-ECs were coated on dextran microcarrier beads (Sigma), suspended within a 3 mg ml −1 solution of bovine fibrinogen (Sigma), and gelled within a No 1.5 thickness 8-well borosilicate chamber slide (Thermo Scientific/Nunc) using 50 U ml −1 (1:25 v:v) thrombin (Sigma). LFs (2 × 10 4 ) were overlaid in 250 µl of EGM2 per well. Cultures were analysed at day 7.
Quantification.
To quantify normalized tumour cell area fraction, a macro was written using NIH ImageJ open source software to remove bias from data quantification. For the YFP channel alone, day 0 images (that is, just after tumour cell seeding) were subjected to the following. Contrast was enhanced such that 0.5% of pixels were saturated. The image was then sharpened and the Find Edges function was applied to further enhance contrast between YFP-positive cells and background. A constant threshold was then applied to all samples within a given experiment to eliminate variability. The total area fraction of the 6 × 6 tiled image occupied by YFP-positive cells was then calculated. For day 10 images, the Find Edges function was not used because it created artefacts within larger tumour clusters. For each image, the measured area fraction at day 10 was normalized by the corresponding day 0 value to account for any small variations in seeding density from well-to-well.
Tumour cell area fraction in zebrafish xenografts was quantified in similar fashion. Zebrafish were imaged immediately after injection (3.5 dpf) with a Zeiss Lumar fluorescence stereoscope, and imaged again post-fixation (7.5 dpf) with a Zeiss LSM 710 confocal microscope. Z -stacks were acquired at the latter time point to image tumour cells throughout the subintestinal space. Only zebrafish that survived to 7.5 dpf with viable mCherry MDA-MB-231 cells in their subintestinal space were quantified. Tumour cell area fractions were measured only for the subintestinal space at 3.5 dpf and 7.5 dpf using the macro described above. Tumour cell area fractions measured at 7.5 dpf were normalized by the corresponding values obtained post-injection to yield normalized tumour cell growth for each animal.
To quantify Ki67-negativity, tumour clusters totally devoid of nuclear Ki67 were counted manually. The Ki67-negative fraction was obtained by dividing this number by the total number of YFP-positive clusters per well.
To analyse tumour cell division time as a function of microvascular sub-niche, a 50 µm × 50 µm grid was superimposed on image sequences loaded into Imaris software to facilitate measurement of the distance between H2B-GFP T4-2 cells and mCherry-positive E4-EC structures. When in question, distances were measured manually using the Measurement Points tool in Imaris. H2B-GFP T4-2 cells were tracked until first evidence of division, and the total time spent in an endothelial tip sub-niche (within 50 µm of a microvascular tip), in an endothelial stalk sub-niche (within 50 µm of microvasculature but not within 50 µm of a tip), or in the stromal sub-niche (>50 µm away from microvasculature) was tabulated for each of 229 cells that could be tracked accurately during the entire 72 h time period. Analysis was conducted in a blinded fashion.
Tip number and branch point density were counted manually using the cell counter application in ImageJ.
Intensity of protein immunofluorescence at endothelial tips and stalks was quantified using NIH ImageJ. A minimum of 15 vessels from 2 separate experiments were quantified to determine the relative intensities of TSP-1, POSTN and active TGF-β1 at the endothelial tip versus endothelial stalk. Images were contrast enhanced (saturated pixels = 0.5%) before analysis. Average intensity of a ∼150 pixel-squared region of a tip cell and a stalk cell two cells away from that tip were measured. Background intensity was subtracted from the measured intensities. Tip and stalk intensities were each normalized by the average intensity obtained for all stalks and reported as normalized average intensities.
Notch1 knockdown. E4ORF1-HUVECs were infected at a multiplicity of infection of 5 with custom-made lentiviruses (Sigma) containing shRNA targeting human Notch1 in a pLKO.1-puro-CMV-TagRFP vector. Empty vector was used as a control (ctrl shRNA). Sequences for shRNA were as follows: sh8393: 5 -CCGGCTTTGTTTCAGGTTCAGTATTCTCGAGAATACTGAACCTGAAAC-AAAGTTTTT-3 ; sh1510: 5 -CCGGCGCTGCCTGGACAAGATCAATCTCGAGAT-TGATCTTGTCCAGGCAGCGTTTTT-3 ; sh2304: 5 -CCGGCAAAGACATGACCA-GTGGCTACTCGAGTAGCCACTGGTCATGTCTTTGTTTTT-3 .
Western blotting. Notch1-shRNA-E4-ECs and control-shRNA-E4-ECs were lysed in 2% SDS/PBS. Twenty micrograms of each lysate was then separated on a Tris-glycine 4-20% gel. Notch1 was probed with a rabbit polyclonal antibody (Abcam ab27526, 1:500). The blot was stripped and re-probed with a rabbit polyclonal antibody against the nuclear membrane protein Lamin A/C, used here as a loading control (Santa Cruz Biotechnology sc-20681, 1:2,000).
LC-MS/MS. Samples were prepared for LC-MS/MS analysis as follows. Cultures
were established for 7 days in EGM-2, washed extensively with PBS to remove medium, and incubated in 0.1% Triton X-100/PBS (with added protease inhibitor cocktail, EMD Biosciences) for 30 min at 4 • C to de-cellularize the cultures. After washing, cultures were incubated overnight at 4 • C in 0.5 M acetic acid solution. The following day, acetic acid was collected and protein was precipitated from the acetic acid solution through TCA/DOC precipitation. The precipitate was washed twice in acetone, dried at room temperature, and then dissolved overnight in 5× Invitrosol LC/MS protein solubilizer (Invitrogen) under constant agitation. Invitrosol was brought to 1× with 25 mM NH 4 (HCO 3 ) and final protein concentration was measured by A 280 nm using a NanoDrop spectrophotometer (Thermo Scientific). Precipitates were stored at −80 • C until analysis.
Immediately before analysis, 30 micrograms of protein from each experimental condition was proteolytically cleaved by modified, sequencing-grade trypsin (Promega) in 50 mM NH 4 (HCO 3 ) digestion buffer containing 1 µg trypsin and 2 mM CaCl 2 for 16 h at 37 • C. Reactions were then acidified with 90% formic acid (2% final) to stop proteolysis. Samples were centrifuged for 30 min at 16,100g to remove insoluble material, and then subjected to LC-MS/MS analysis.
Methods for LC-MS/MS and tandem mass spectra analysis were conducted essentially as described previously 64 . The resulting list of proteins was culled to ECM proteins and related growth factors/cytokines by referencing protein ontology in http://www.uniprot.org. Spectral counts for each condition were normalized by one another and log 2 values of those products were plotted in heat-map format using TreeView open source software. 
